We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RYA:EURONEXT DUBLINRyanair Holdings PLC Analysis

Data as of 2026-03-12 - not real-time

$11.20

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Rayonier Advanced Materials is trading at $11.20, just below its recent resistance of $11.28 and comfortably above the calculated support of $7.15, with the 20‑day SMA (9.12) sitting above both the 50‑day (8.27) and 200‑day (6.19) averages, confirming a strong bullish trend. The RSI of 68 and a bullish MACD histogram (+0.19) further underscore short‑term momentum, while volume is on an increasing trajectory, suggesting fresh buying interest. However, the 30‑day volatility of over 124% and a beta around 1.4 signal pronounced price swings, and the company’s fundamentals remain fragile: a negative profit margin of –28.7%, a debt‑to‑equity ratio exceeding 245%, and negative free cash flow of $‑75 M. Despite these challenges, the forward PE of 8.5, a price‑to‑sales multiple of 0.51, and an analyst consensus “buy” with a target price of $14.50 imply the stock is undervalued with roughly 29% upside potential. The recent 13% price jump following the announcement of an American Industrial Partners stake purchase adds a positive catalyst, but the high leverage and ongoing earnings losses mean investors should monitor cash‑flow generation closely.
On balance, the technical picture is robust and the valuation appears attractive, yet the company’s balance sheet and profitability concerns inject considerable risk. The sector’s exposure to environmental regulations adds a medium‑level regulatory headwind, while the global footprint across the U.S., China, and Europe spreads geographic risk. Given the mix of strong momentum, undervalued metrics, and significant financial constraints, the stock is best viewed as a high‑conviction medium‑term play with caution advised on short‑term overbought conditions.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish technical indicators (SMA alignment, MACD, RSI)
  • Recent news‑driven price rally
  • Overbought momentum and high short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued forward PE and price‑to‑sales ratios
  • Analyst target price indicating ~30% upside
  • Potential earnings turnaround reflected in forward EPS

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Structural demand for cellulose specialty products
  • Heavy debt load and negative cash flow limiting flexibility
  • Exposure to environmental and regulatory shifts in chemicals

Key Metrics & Analysis

Financial Health

Revenue Growth-1.20%
Profit Margin-28.69%
P/E Ratio8.5
ROE-80.43%
ROA0.39%
Debt/Equity245.74
P/B Ratio2.4
Op. Cash Flow$23.9M
Free Cash Flow$-75546000

Technical Analysis

TrendBullish
RSI68.2
Support$7.15
Resistance$11.28
MA 20$9.12
MA 50$8.27
MA 200$6.19
MACDBullish
VolumeIncreasing
Fear & Greed Index78.16

Valuation

Target Price$14.50
Upside/Downside29.46%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta1.36
Volatility124.49%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.